CVE-2024-11013

Description

Command Injection vulnerability in NEC Corporation UNIVERGE IX from Ver9.2 to Ver10.10.21, for Ver10.8 up to Ver10.8.27, for Ver10.9 up to Ver10.9.14 and UNIVERGE IX-R/IX-V Ver1.2.15 and earlier allows a attacker to inject an arbitrary CLI commands to be executed on the device via the management interface.

Category

7.2
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.26%
Affected: NEC Corporation UNIVERGE IX
Affected: NEC Corporation UNIVERGE IX
Affected: NEC Corporation UNIVERGE IX
Affected: NEC Corporation UNIVERGE IX-R/IX-V
Published at:
Updated at:

References

Link Tags
https://https://jpn.nec.com/security-info/secinfo/nv24-009_en.html

Frequently Asked Questions

What is the severity of CVE-2024-11013?
CVE-2024-11013 has been scored as a high severity vulnerability.
How to fix CVE-2024-11013?
To fix CVE-2024-11013, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-11013 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-11013 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-11013?
CVE-2024-11013 affects NEC Corporation UNIVERGE IX, NEC Corporation UNIVERGE IX, NEC Corporation UNIVERGE IX, NEC Corporation UNIVERGE IX-R/IX-V.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.